Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Targeting triple‐negative breast cancer with an aptamer‐functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies

Fig. 1

Characterization of HMSN. a, b Typical Transmission electron microscopic (TEM) images of MMT-2 (a) and LXL-1-PpIX-MMT-2 (b). c Thermogravimetric analysis (TGA) data of M-MMT-2 and M-PpIX-MMT-2. d Fourier-transform infrared spectroscopic (FTIR) spectra of MMT-2, M-MMT-2, and M-PpIX-MMT-2. Assignment of the IR peaks: (i) N-H stretching of secondary amine; (ii) C-H stretching of alkanes; (iii) C = O stretching; (iv) N-H bending of amide; (v) C-H bending of alkanes; (vi) C = C bending. e Zetasizer confirmed the size and zeta potential of our MSN nanoparticles using the techniques of Dynamic Light Scattering (DLS) and Electrophoretic Light Scattering (ELS)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us